Protocol summary

Study aim
This study aims to investigate the metabolic profile of middle-aged obese individuals through the incorporation of beetroot juice (BRJ), caffeine, and high-intensity interval training (HIIT).
Design
The clinical trial will have a control group, with parallel groups, double-blind, and a sample size of 80 with a random sequence using the randomizeR package in R software and will be divided into four groups.
Settings and conduct
All groups perform the HIIT program, which is conducted at the university gym of Halabja, Iraq, under the guidance of an exercise physiologist, utilizing a motorized treadmill. Participants are unaware of which group they are assigned to and whether they are receiving active supplements, placebos, or a combination.
Participants/Inclusion and exclusion criteria
The inclusion criteria comprise men with obesity (BMI ≥30 kg/m²), stable weight, a sedentary lifestyle, no history of cardiovascular or metabolic disorders, and no consumption of nutritional supplements.The exclusion criteria include chronic illnesses, tobacco use, recent nitrate supplementation, or regular caffeine consumption.
Intervention groups
Participants are categorized into four groups: (1) placebo, (2) beetroot juice, (3) caffeine, and (4) beetroot juice combined with caffeine.All groups engage in identical high-intensity interval training programs.
Main outcome variables
Anthropometric (body composition, VO₂ peak), blood analysis (IL-6, TNF-α, CRP, IL-10, NOx, NO, and eNOS, OxLDL, TOS, OSI, and TBARS, troponin I and T, CK-MB and CK-T, lipid profile, glucose, and insulin).

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20250531066002N1
Registration date: 2025-09-28, 1404/07/06
Registration timing: prospective

Last update: 2025-09-28, 1404/07/06
Update count: 0
Registration date
2025-09-28, 1404/07/06
Registrant information
Name
Dara Latif Saifalddin
Name of organization / entity
University of ‌Halabja
Country
Iran (Islamic Republic of)
Phone
+98 87 3452 1914
Email address
dara.saifaddin@uoh.edu.iq
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2025-10-23, 1404/08/01
Expected recruitment end date
2025-10-23, 1404/08/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The combination effects of Beetroots Juice and Caffeine with High-Intensity Interval Training on cardiovascular risk factors in Middle-Aged Obese Men
Public title
Effects of exercise training and dietary supplements (beetroot juice and caffeine) on cardiovascular risk factors in obese men
Purpose
Basic scienece
Inclusion/Exclusion criteria
Inclusion criteria:
Obese men (BMI ≥30 kg/m²) Stable weight (±2 kg) for three months A sedentary lifestyle (<60 minutes/week of structured exercise in the past 6 months) No history of cardiovascular or metabolic illnesses, No use of nutritional supplements
Exclusion criteria:
Chronic illnesses Tobacco use Recent nitrate supplementation Habitual caffeine intake above 200 mg per day
Age
From 30 years old to 50 years old
Gender
Male
Phase
0
Groups that have been masked
  • Participant
  • Care provider
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 72
Randomization (investigator's opinion)
Randomized
Randomization description
A stratified randomized block design was implemented, considering peak oxygen consumption and body mass index, with two degrees of fitness and body fat %. Randomly interspersed permuted blocks of sizes 4 and 8 were utilized to reduce predictability. Randomization was conducted at the individual level, with each participant independently assigned to one of four groups. Randomization sequences were produced with the randomizeR program within the R software environment. Within each stratum, groups of 4 or 8 allocations were established. Strict confidentiality was kept through the utilization of sealed, opaque, serially numbered envelopes (SNOSE), which were arranged in a sequence tailored to each stratum. Every envelope included a folded allocation card. Following baseline assessments, recruitment personnel accessed the subsequent envelope in the strata relevant to the participant. The envelopes were stored in a secured cabinet accessible just to the trial coordinator.
Blinding (investigator's opinion)
Double blinded
Blinding description
Participant blinding: Subjects remain uninformed about their group assignment and whether they are getting active supplements, a placebo, or a combination of both. They are aware that the supplements are probably caffeine, beetroot juice, a combination of both, or a placebo. They are also unable to discern their supplement kind from flavor, look, or packaging. Moreover, practitioners engaged in direct engagement with participants (e.g., conducting training sessions, administering supplements, collecting performance data, evaluating results, and analyzing data) remain uninformed about the group type, therefore identifying groups solely by code (Group A, B, C, or D). To preserve blindness, beetroot juice placebos typically consist of nitrate-free beetroot juice or an inert beverage that resembles the color and flavor of beetroot juice. The caffeine and placebo are indistinguishable tablets, frequently opaque. All supplements were made by individuals not participating in the intervention. All participants, irrespective of group affiliation, got two items (a beverage and a pill) every day or prior to exercise.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
The ethical committee Ethical Committee for Human Studies at the University of Halabja
Street address
Research Center University of Halabja, Zanko Street
City
Halabja
Postal code
46018
Approval date
2026-09-24, 1405/07/02
Ethics committee reference number
09 2025/01

Health conditions studied

1

Description of health condition studied
Obesity
ICD-10 code
E66
ICD-10 code description
Overweight and obesity

Primary outcomes

1

Description
Interleukine-6
Timepoint
Before starting intervention, and 48 hours after the last training session.
Method of measurement
Elisa

2

Description
Interleukine-10
Timepoint
Before starting intervention, and 48 hours after the last training session.
Method of measurement
Elisa

3

Description
TNF-α
Timepoint
Before starting intervention, and 48 hours after the last training session.
Method of measurement
Elisa

4

Description
C-reactive protein
Timepoint
Before starting intervention, and 48 hours after the last training session.
Method of measurement
Elisa

5

Description
Leptin
Timepoint
Before starting intervention, and 48 hours after the last training session.
Method of measurement
Elisa

6

Description
Adiponectin
Timepoint
Before starting intervention, and 48 hours after the last training session.
Method of measurement
Elisa

7

Description
Nitric oxide
Timepoint
Before starting intervention, and 48 hours after the last training session.
Method of measurement
Elisa

8

Description
Endothelial nitric oxide synthase
Timepoint
Elisa
Method of measurement
Before starting intervention, and 48 hours after the last training session

9

Description
Oxidized low-density lipoprotein
Timepoint
Before starting intervention, and 48 hours after the last training session
Method of measurement
Elisa

10

Description
Plasma nitrate + nitrite (NOx) concentrations
Timepoint
Before starting intervention, and 48 hours after the last training session.
Method of measurement
Griess assay and immunoassay techniques

11

Description
Insulin
Timepoint
Before starting intervention, and 48 hours after the last training session.
Method of measurement
Elisa

12

Description
Total antioxidant status
Timepoint
Before starting intervention, and 48 hours after the last training session
Method of measurement
Using a microplate reader on serum samples with a commercial kit

13

Description
Total oxidant status (TOS)
Timepoint
Before starting intervention, and 48 hours after the last training session
Method of measurement
Using a microplate reader on serum samples with a commercial kit

14

Description
Plasma thiobarbituric acid-reactive substances
Timepoint
Before starting intervention, and 48 hours after the last training session
Method of measurement
Fluorescent thiobarbituric acid (TBA) assay.

15

Description
Total cholesterol
Timepoint
Before starting intervention, and 48 hours after the last training session
Method of measurement
Utilizing an auto-analyzer and suitable kits

16

Description
Triglycerides
Timepoint
Before starting intervention, and 48 hours after the last training session.
Method of measurement
Utilizing an auto-analyzer and suitable kits

17

Description
Low-density lipoprotein cholesterol
Timepoint
Before starting intervention, and 48 hours after the last training session.
Method of measurement
Utilizing an auto-analyzer and suitable kits

18

Description
High-density lipoprotein cholesterol
Timepoint
Before starting intervention, and 48 hours after the last training session.
Method of measurement
Utilizing an auto-analyzer and suitable kits

19

Description
Troponin I
Timepoint
Before starting intervention, and 48 hours after the last training session.
Method of measurement
Utilizing an auto-analyzer and suitable kits

20

Description
Troponin T
Timepoint
Before starting intervention, and 48 hours after the last training session.
Method of measurement
Utilizing an auto-analyzer and suitable kits

21

Description
Creatine kinase-MB
Timepoint
Before starting intervention, and 48 hours after the last training session.
Method of measurement
Utilizing an auto-analyzer and suitable kits

22

Description
Creatine kinase-T
Timepoint
Before starting intervention, and 48 hours after the last training session.
Method of measurement
Utilizing an auto-analyzer and suitable kits

23

Description
Glucose
Timepoint
Before starting intervention, and 48 hours after the last training session.
Method of measurement
Utilizing an auto-analyzer and suitable kits

Secondary outcomes

1

Description
Body composition
Timepoint
Before starting intervention, and 48 hours after the last training session.
Method of measurement
Body composition analyzer

2

Description
VO₂ peak
Timepoint
Before starting intervention, and 48 hours after the last training session.
Method of measurement
A graded exercise test on a treadmill

Intervention groups

1

Description
Intervention group 1: beetroot juice: a daily dosage of 70 mL of concentrated beetroot juice (Beet-It Sport Shot 400; James White Ltd, Ashbocking, UK), which contains 400 mg (6.4 mmol) of NO₃⁻ and capsules containing maltodextrin comparable to caffeine capsules. In addition, they perform high-intensity interval training (on a motorized treadmill for 4 × 4-minute intervals at 70-90% of maximum heart rate (HRmax), interspersed with 3 minutes of active recovery) 3 times a week.
Category
Other

2

Description
Intervention group 2: Caffeine, at a dosage of 6 mg/kg of body weight daily, using pharmaceutical-grade capsules, and a beverage consisting of 1 g of powdered beetroot juice mixed with 1 L of mineral water and lemon juice, akin to the beetroot juice bottle. In addition, they perform high-intensity interval training (on a motorized treadmill for 4 × 4-minute intervals at 70-90% of maximum heart rate (HRmax), interspersed with 3 minutes of active recovery) 3 times a week.
Category
Other

3

Description
Intervention group 3: caffeine plus beetroot juice; caffeine, a dosage of 6 mg/kg of body weight daily, using pharmaceutical-grade capsules. Moreover, a daily dosage of 70 mL of concentrated beetroot juice (Beet-It Sport Shot 400; James White Ltd, Ashbocking, UK), which contains 400 mg (6.4 mmol) of NO₃⁻, and a placebo capsule similar to a caffeine-containing capsule. In addition, they perform high-intensity interval training (on a motorized treadmill for 4 × 4-minute intervals at 70-90% of maximum heart rate (HRmax), interspersed with 3 minutes of active recovery) 3 times a week.
Category
Other

4

Description
Intervention group 4: (control-placebo); the placebo group will administer capsules containing maltodextrin comparable to caffeine capsules, along with a beverage consisting of 1 g of powdered beetroot juice mixed with 1 L of mineral water and lemon juice, akin to the beetroot juice bottle, at a specific time.
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
University of Halabja
Full name of responsible person
Dara Latif Saifalddin
Street address
Research Center University of Halabja, Zanko Street
City
Halabja
Postal code
46018
Phone
+964 751 702 5070
Email
dara.saifaddin@uoh.edu.iq

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
The university of Halabja
Full name of responsible person
Hasan Hashem Abdollah
Street address
Research Center University of Halabja, Zanko Street
City
Halabja
Postal code
46018
Phone
+964 770 282 7151
Email
hassan.abdulla@uoh.edu.iq
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
The university of Halabja
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
The University of Halabja
Full name of responsible person
Dara Latif Saifalddin
Position
Assistant professor
Latest degree
Ph.D.
Other areas of specialty/work
Physiology
Street address
Research Center University of Halabja, Zanko Street
City
Halabja
Province
Halabja province, Kurdistan region
Postal code
46018
Phone
+964 750 107 6597
Email
dara.saifaddin@uoh.edu.iq

Person responsible for scientific inquiries

Contact
Name of organization / entity
University of Halabja
Full name of responsible person
Dara Latid Saifalddin
Position
Assistant professor
Latest degree
Ph.D.
Other areas of specialty/work
Physiology
Street address
Research Center University of Halabja, Zanko Street
City
Halabja
Province
Halabja province, Kurdistan region
Postal code
46018
Phone
+964 750 107 6597
Email
dara.saifaddin@uoh.edu.iq

Person responsible for updating data

Contact
Name of organization / entity
University of Halabja
Full name of responsible person
Dara Latif Saifalddin
Position
Assistant professor
Latest degree
Ph.D.
Other areas of specialty/work
Physiology
Street address
Research Center University of Halabja, Zanko Street
City
Halabja
Province
Halabja province, Kurdistan region
Postal code
46018
Phone
+964 750 107 6597
Email
dara.saifaddin@uoh.edu.iq

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Not applicable
Data Dictionary
Not applicable
Title and more details about the data/document
There is a plan to share the results of this study in a manuscript which may publish finally.
When the data will become available and for how long
After finishing the intervention and analyzing data, and writing the manuscript the data will be published as the journal allows.
To whom data/document is available
To the reviewers of journals which publishes our manuscript.
Under which criteria data/document could be used
There is no restricted condition except the private information regarding the subjects.
From where data/document is obtainable
The person responsible to this document is Dara Latif Saifalddin which can be available via email address: dara.saifaddin@uoh.edu.iq
What processes are involved for a request to access data/document
Academic person can request the document after publishing the data, and the will get answer as soon as possible.
Comments
Loading...